Transient loss of Polycomb components induces an epigenetic cancer fate
V. Parreno,
V. Loubiere,
B. Schuettengruber,
L. Fritsch,
C. C. Rawal,
M. Erokhin,
B. Győrffy,
D. Normanno,
M. Stefano,
J. Moreaux,
N. L. Butova,
I. Chiolo,
D. Chetverina,
A.-M. Martinez () and
G. Cavalli ()
Additional contact information
V. Parreno: University of Montpellier
V. Loubiere: University of Montpellier
B. Schuettengruber: University of Montpellier
L. Fritsch: University of Montpellier
C. C. Rawal: University of Southern California
M. Erokhin: Russian Academy of Sciences
B. Győrffy: Semmelweis University Department of Bioinformatics
D. Normanno: University of Montpellier
M. Stefano: University of Montpellier
J. Moreaux: University of Montpellier
N. L. Butova: University of Southern California
I. Chiolo: University of Southern California
D. Chetverina: Russian Academy of Sciences
A.-M. Martinez: University of Montpellier
G. Cavalli: University of Montpellier
Nature, 2024, vol. 629, issue 8012, 688-696
Abstract:
Abstract Although cancer initiation and progression are generally associated with the accumulation of somatic mutations1,2, substantial epigenomic alterations underlie many aspects of tumorigenesis and cancer susceptibility3–6, suggesting that genetic mechanisms might not be the only drivers of malignant transformation7. However, whether purely non-genetic mechanisms are sufficient to initiate tumorigenesis irrespective of mutations has been unknown. Here, we show that a transient perturbation of transcriptional silencing mediated by Polycomb group proteins is sufficient to induce an irreversible switch to a cancer cell fate in Drosophila. This is linked to the irreversible derepression of genes that can drive tumorigenesis, including members of the JAK–STAT signalling pathway and zfh1, the fly homologue of the ZEB1 oncogene, whose aberrant activation is required for Polycomb perturbation-induced tumorigenesis. These data show that a reversible depletion of Polycomb proteins can induce cancer in the absence of driver mutations, suggesting that tumours can emerge through epigenetic dysregulation leading to inheritance of altered cell fates.
Date: 2024
References: Add references at CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.nature.com/articles/s41586-024-07328-w Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:629:y:2024:i:8012:d:10.1038_s41586-024-07328-w
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/s41586-024-07328-w
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().